RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss ST Sensata narrowly misses Q4 2025 EPS estimates shares dip 041 in todays trading CRVL CorVel shares rise one percent following the release of its 2026 first quarter earnings report